Navigation Links
Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
Date:4/7/2013

SAN DIEGO and FOUNTAIN VALLEY, Calif., April 8, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq™) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th). IGDRASOL is a privately-held company for which STI was granted an irrevocable option right to acquire.  The two companies' combined pipeline features an oncology franchise of potential products with Phase 2/3 data for multiple solid tumor indications as well as two synergistic drug discovery and development platforms, namely the G-MAB® human antibody library and MABiT™, a proprietary technology to generate antibody formulated drug conjugates (AfDC).

Cynviloq™ (or IG-001) is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries as Genexol-PM®. Cynviloq™ has completed Phase 1 or 2 trials in MBC, NSCLC, pancreatic cancer, ovarian cancer and bladder cancer in the US and/or non-US. IGDRASOL is preparing for an "End of Phase 2" meeting with the U.S. Food & Drug Administration (FDA) targeted for the first half of 2013 regarding Cynviloq™.  As an injectable nanoparticle formulation of paclitaxel, Cynviloq™ is potentially eligible for approval via FDA's 505(b)(2) regulatory pathway versus albumin-bound paclitaxel (nab-paclitaxel; Abraxane®) in its currently approved metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC) indications.

IG-004 (formerly known as TOCOSOL® paclitaxel) is a TPGS-based emulsion of paclitaxel, which was recently acquired from
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
2. Sorrento Therapeutics Awarded Third Phase I STTR Grant
3. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
6. Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
7. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
8. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
9. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
10. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
11. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... DUBLIN , March 2, 2015   ... device businesses for a total consideration of up to $1.65 ... Endo also evaluating strategic alternatives for AMS, Women,s Health ... into a global specialty pharmaceuticals business ... today announced it has entered into a definitive agreement with ...
(Date:3/2/2015)... WOODLANDS, Texas , March 2, 2015   ... a biopharmaceutical company focused on developing breakthrough treatments for ... end 2014 financial results on Wednesday, March 4, 2015 ... a conference call and webcast to discuss clinical development ... year end of 2014 at 10:00 a.m. Eastern Time ...
(Date:3/2/2015)... ANGELES , March 2, 2015 ImmunoCellular Therapeutics, Ltd. ... financial results for the year ended December 31, 2014 on March ... conference call and webcast on Thursday, March 12, 2015, at 5:00 ... , President and CEO.   , ... dial-in: (631) 291-4544; conference code 92238648. , , , ...
Breaking Medicine Technology:Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2
... SALT LAKE CITY , May 11 Dynatronics Corporation (Nasdaq: DYNT ... during the morning of Monday, May 17, 2010 .   , ... Dynatronics has scheduled a conference call for investors later that ...  Those interested in participating should call 800-861-4084 and use passcode: 9921511. , ...
... 11 RF Technologies®, a leading provider of healthcare safety and ... use with Safe Place® Infant Security Solutions. The soft, stretchy banding material ... staff when a Safe Place bracelet is loose, tampered with or is ... Smart Sense ...
Cached Medicine Technology:Smart Sense(TM) From RF Technologies Upgrades Safe Place(R) Bracelets Using Industry-Leading Infant Security Technology, Fit and Comfort 2
(Date:3/2/2015)... 02, 2015 New York singer/songwriter ... be delivering a plenary address entitled Finding the ... Art of Healing and Recovery at this year’s ... Healthcare Executive Summit (BHES).     , With more than ... have been recorded by some of the biggest ...
(Date:3/2/2015)... 2015 This year, the National Multiple Sclerosis ... provide opportunities for people across the country to unite, ... with MS live their best lives. MS Awareness Week is ... others to join the Society’s vision of a world free ... disabling disease of the central nervous system, interrupts the flow ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Regulatory ... focused on quality, regulatory and technical consulting, announces ... Chief Operating Officer. , Before joining RCA, ... leading R&D teams in all aspects of developing ... positions at Covidien (Medtronic), Regulatory Compliance Associates Inc., ...
(Date:3/2/2015)... Many mainstream media outlets have run stories ... how much of that news reporting is true? Many ... measles, but whose youngsters later developed autism, will assemble ... comprised of professionals, clinicians, researchers, therapists, advocates, and others. ... questions about the body and childhood health will have ...
(Date:3/1/2015)... Clearwater, Florida (PRWEB) March 02, 2015 ... market their services and manage their practices ... offer an integrated all-inclusive solution. The ... development program and a medical practice management ... success and long-term financial sustainability. A referral ...
Breaking Medicine News(10 mins):Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4
... the potentially fatal tick-borne illness has nearly tripled, research shows ... Rocky Mountain spotted fever in the United States almost tripled ... , The potentially fatal disease is caused by Rickettsia ... bite of the dog tick or Rocky Mountain wood tick. ...
... The Board of,Directors of Colgate-Palmolive Company (NYSE: ... common share, payable on November 15, 2007, to,shareholders of ... dividends on its common stock since 1895. * ... global consumer,products company, tightly focused on Oral Care, Personal ...
... more options ... consumers, health professionals, WASHINGTON, Oct. 4 The U.S. ... the number and,variety of generic drug products available to consumers ... brand-name,counterparts and competition among generics has been a key factor ...
... R.I. [Brown University] The chemical process known as ... transduction a fundamental biochemical cascade inside cells that ... A team of cell biologists led by Eugene Chin, ... School of Brown University and a staff researcher at ...
... collaboration ... between physicians and patients, CHICAGO, Oct. 4 Allscripts ... and information,solutions that physicians use to improve healthcare, was featured ... announcing the new consumer health platform. Allscripts is the,first market-leading ...
... 4 GeoPharma, Inc. (Nasdaq:,GORX) (the "Company") GeoPharma, ... among a select group invited to present at ... Thursday, October 11, 2007 at 9:25 AM,(PDT). ... history of,isolating quality small cap companies that perform ...
Cached Medicine News:Health News:Surge in U.S. Cases of Rocky Mountain Spotted Fever 2Health News:FDA Announces Initiative to Bolster Generic Drug Program 2Health News:Brown researchers make major signal transduction discovery 2Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 2Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 3Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 4Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 5Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 6Health News:GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference 2Health News:GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference 3
... FLUORAT®-02-PANORAMA spectrofluorometer ... sophisticated instrument among ... It is intended ... chromatographic analysis, and ...
Inquire...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
Medicine Products: